Summary
Mean platelet volume (MPV) is an early marker of platelet activation. Larger platelets, compared to small ones, increase platelet adhesion and aggregation, and present a higher thrombotic activity. Some studies have explored the association between MPV and the morbidity of portal vein thrombosis (PVT). The aim of this study was to evaluate the predictive effect of MPV in patients with PVT by a meta-analysis. We searched Pubmed, Web of Science, SCOPUS, OVID, CNKI and CBMD from database inception to September 13,2017. Seven studies in accordance with selection criteria were included. The extraction of basic data was independently conducted by two reviewers. The mean difference in MPV between PVT patients and controls were pooled with weighted mean difference (WMD) and 95% confidence interval of 0.88 fl (95% CI: 0.61-1.15). A random-effect model was chosen for an obvious heterogeneity in the pooling (Chi-square=27.12, df=6, P<000l, I2=77.9%). The sources of heterogeneity were from the difference of primary disease of participants and portal vein diameter. Taken together, our results reveal that MPV is a predictive indicator in patients with PVT.
Similar content being viewed by others
References
Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol, 2014, 11(7):435–446
Parikh S, Shah R, Kapoor P. Portal vein thrombosis. Am J Med, 2010, 123(2):111–119
Maruyama H, Okugawa H, Takahashi M, et al. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol, 2013, 108(4):568–574
Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol, 2009, 51(4):682–689
Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut, 2005, 54(5):691–697
Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol, 2004, 40(5):736–741
Cagin YF, Atayan Y, Erdogan MA, et al. Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients. Hepatobiliary Pancreat Dis Int, 2016, 15(5):499–503
Fujiyama S, Saitoh S, Kawamura Y, et al. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome. BMC Gastroenterol, 2017, 17(1):112
Qi X, Chen H, Han G. Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: a meta-analysis. Am J Med Sei, 2013, 346(1):38–44
Pellicelli AM, D’Ambrosio C, Barbara G, et al. Clinical and Genetic factors associated to development of portal vein thrombosis in cirrhotic patients without hepatocellular carcinoma. J Hepatol, 2011, 54 (Suppl 1):S77
Mangia A, Villani MR, Cappucci G, et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol, 2005, 17(7):745–51
Colkesen Y, Muderrisoglu H. The role of mean platelet volume in predicting thrombotic events. Clin Chem Lab Med, 2012, 50(4):631–634
Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis, 1996, 7(2):157–161
Jakubowski JA, Adler B, Thompson CB, et al. Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction. J Lab Clin Med, 1985, 105(2):271–276
Thompson CB, Jakubowski JA, Quinn PG, et al. Platelet size as a determinant of platelet function. J Lab Clin Med, 1983, 101(2):205–213
Bath PM. The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thromb Haemost, 1993, 70(4):687–690
Cemin R, Donazzan L, Lippi G, et al. Blood cells characteristics as determinants of acute myocardial infarction. Clin Chem Lab Med, 2011, 49(7):1231–1236
Zandecki M, Genevieve F, Gerard J, et al. Spurious counts and spurious results on haematology analysers: a review. Part I: platelets. Int J Lab Hematol, 2007, 29(1):4–20
Kilicli-Camur N, Demirtunc R, Konuralp C, et al. Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sei Monit, 2005, 1 l(8):Cr387–392
Greisenegger S, Endler G, Hsieh K, et al. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke, 2004, 35(7):1688–1691
Pizzulli L, Yang A, Martin JF, et al. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J, 1998, 9(1):80–84
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. Int J Surg, 2010, 8(5):336–341
Aliosmanoglu I, Gui M, Oguz A, et al. Can mean platelet volume be a new risk factor in portal venous thrombosis? Clin Appl Thromb Hemost, 2013, 19(4):433–436
Abdel-Razik A, Mousa N, Elhelaly R, et al. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the model for end-stage liver disease scoring system. Eur J Gastroenterol Hepatol, 2015, 27(5):585–592
Qian YY, Li K. The early prevention and treatment of PVST after laparoscopic splenectomy: A prospective cohort study of 130 patients. Int J Surg, 2017, 44:147–151
Girleanu I, Trifan A, Cojocariu C, et al. Platelet indices in patients with de novo portal vein thrombosis and liver cirrhosis. Rev Med Chir Soc Med Nat Iasi, 2013, 117(3):641–647
He S, He F. Predictive model of portal venous system thrombosis in cirrhotic portal hypertensive patients after splenectomy. Int J Clin Exp Med, 2015, 8(3):4236–4242
He S, Fan X, Shi X, et al. Risk factors for portal vein thrombosis after splenectomy for portal hypertension due to liver cirrhosis and establishment of its prediction model. Chin J General Surg (Chinese), 2016, 25(12):1766–1772
Zhang Q, Guo LY. Analysis of risk factors for portal vein thrombosis in cirrhosis. Med Philosop (Chinese), 2015, 12:32–34
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2011. Available from www. handbook, cochrane. org.
Dickson BC. Virchow’s triad. Br J Haematol, 2009, 145(3):433
Beyazit Y, Sayilir A, Torun S, et al. Mean platelet volume as an indicator of disease severity in patients with acute pancreatitis. Clin Res Hepatol Gastroenterol, 2012, 36(2):162–168
Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des, 2011, 17(1):47–58
Grove EL, Hvas AM, Mortensen SB, et al. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost, 2011, 9(1):185–191
Qi X, De Stefano V, Li H, et al. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Eur J Intern Med, 2015, 26(1):23–29
Amitrano L, Guardascione MA, Menchise A, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol, 2010, 44(6):448–451
Senzolo M, Ferronato C, Burra P, Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered. Intern Emerg Med, 2009, 4(2):161–162
Cao X, Xie X, Zhou J, et al. Increased platelet volume in a general population with prehypertension: a cross-sectional study of 80545 participants from China. Hypertens Res, 2012, 35(9):903–908
Ntaios G, Gurer O, Faouzi M, et al. Hypertension is an independent predictor of mean platelet volume in patients with acute ischaemic stroke. Intern Med J, 2011, 41(9):691–695
Nadar SK, Blann AD, Kamath S, et al. Platelet indexes in relation to target organ damage in highrisk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol, 2004, 44(2):415–422
Tetikoglu M, Aktas S, Sagdik HM, et al. Mean Platelet Volume is Associated with Diabetic Macular Edema in Patients with Type-2 Diabetes Mellitus. Semin Ophthalmol, 2017, 32(5):651–654
Shah B, Sha D, Xie D, et al. The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999–2004. Diabetes Care, 2012, 35(5):1074–1078
Acknowledgments
We would like to appreciate the researchers and study participants for their contributions.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by the National Natural Science Foundation of China (No. 81500109).
Rights and permissions
About this article
Cite this article
Lin, Wy., Lu, X., Fan, Fj. et al. Predictive Effect of Mean Platelet Volume in Patients with Portal Vein Thrombosis: A Meta-analysis of Case-control Studies. CURR MED SCI 38, 575–581 (2018). https://doi.org/10.1007/s11596-018-1916-z
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-018-1916-z